This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Monocytic leukaemia
CD2_MONOCYTIC_LEUKAEMIA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
121 |
4. Check minimum number of eventsNone |
121 |
5. Include endpointsNone |
121 |
6. Filter based on genotype QC (FinnGen only) |
113 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia monocytica
Similar endpoints
↥List of similar endpoints to
Monocytic leukaemia
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 113 | 49 | 64 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 68.52 | 64.22 | 71.81 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 121
- Matched controls
- 1210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
45.3
101.9
75
42
XW000
NOMESCO Finland
Bone marrow biopsy
28.1
69.5
56
36
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
68.3
59
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
38.6
35
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
136.6
37.2
38
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
36.3
33
*
WW500
NOMESCO Finland
Blood transfusion
10.1
23.7
31
40
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
79.0
18.3
20
*
Z51.5
ICD-10 Finland
Palliative care
6.7
17.7
34
67
D64.9
ICD-10 Finland
Anaemia, unspecified
5.9
17.6
41
97
M04AA01
ATC
allopurinol; systemic
5.5
17.6
47
126
A04AA01
ATC
ondansetron; systemic, rectal
6.5
16.6
32
63
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.2
15.4
41
108
L01XX05
ATC
hydroxycarbamide; oral
41.8
14.9
18
5
R50.9
ICD-10 Finland
Fever, unspecified
4.6
13.3
42
126
C93.9
ICD-10 Finland
Monocytic leukaemia, unspecified
+∞
12.7
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
12.7
38
109
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
72.1
11.9
13
*
B03XA02
ATC
darbepoetin alfa; parenteral
16.9
9.8
15
10
A05AA02
ATC
ursodeoxycholic acid; oral
33.0
9.6
12
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.0
8.9
15
13
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
8.4
8
*
127
Kela drug reimbursment
Transplant complication
24.0
8.2
11
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.0
7.9
16
20
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
48.1
7.8
9
*
WW200
NOMESCO Finland
Immunization
13.1
7.8
13
11
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
7.4
7
*
L03AA02
ATC
filgrastim; parenteral
7.8
7.3
16
23
J05AB11
ATC
valaciclovir; oral
3.3
7.0
32
119
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
42.5
6.8
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.9
6.7
16
26
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.3
6.7
11
9
L04AA01
ATC
[U] ciclosporin
73.6
6.5
7
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
6.3
53
274
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
28.3
6.3
8
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
6.3
6
*
G93.0
ICD-10 Finland
Cerebral cysts
+∞
6.3
6
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
6.1
16
40
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
34
13.52
31.56
5.1
2.1
—
—
—
0
0
45
171
3.60
9.89
7.2
3.5
0.80
0.80
mmol/l
0.21
45
158
20
32
7.27
8.46
2.8
1.8
—
—
—
0
0
8
0
+∞
8.42
1.0
0.0
—
—
—
0
0
20
33
7.04
8.28
2.7
1.8
—
—
—
0
0
17
24
8.05
7.80
2.9
1.8
—
—
—
0
0
12
10
13.15
7.25
2.3
2.5
—
—
—
0
0
12
10
13.15
7.25
2.3
2.5
—
—
—
0
0
16
24
7.51
7.09
3.1
1.9
—
—
—
0
0
16
24
7.51
7.09
3.1
1.9
—
—
—
0
0
18
34
6.03
6.79
2.6
2.2
87.83
85.62
%
0.17
18
34
11
9
13.29
6.73
4.0
2.3
—
—
—
0
0
40
187
2.70
5.76
4.1
2.0
—
—
—
0
0
23
79
3.36
5.67
2.8
1.6
—
—
—
0
0
21
69
3.47
5.54
1.8
1.4
—
—
—
0
0
47
244
2.51
5.42
16.1
2.4
—
—
—
0
0
10
11
9.78
5.40
1.6
1.3
—
—
—
0
0
15
31
5.37
5.33
1.4
1.4
—
—
—
0
0
16
45
3.94
5.25
3.1
1.4
6.69
7.83
g/l
1.30
16
39
16
45
3.94
5.25
3.1
1.4
—
—
—
0
0
16
45
3.94
5.25
3.1
1.4
3.65
3.67
g/l
0.02
16
39
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
13
23
6.20
5.23
1.8
1.3
—
—
—
0
0
8
6
14.14
5.15
4.8
2.2
—
—
—
0
0
8
6
14.14
5.15
4.8
2.2
—
—
—
0
0
8
6
14.14
5.15
4.8
2.2
—
—
—
0
0
8
6
14.14
5.15
4.8
2.3
—
—
—
0
0
8
6
14.14
5.15
4.8
2.3
—
—
—
0
0
15
33
5.04
5.07
1.7
1.4
—
—
—
0
0
10
13
8.27
4.96
20.2
5.1
—
—
—
0
0
15
42
3.94
4.94
3.2
1.4
3.35
3.11
g/l
0.23
15
36
10
14
7.67
4.76
4.1
2.1
—
—
—
0
0
10
14
7.67
4.76
4.1
2.1
—
—
—
0
0
10
14
7.67
4.76
4.1
2.1
—
—
—
0
0
27
114
2.76
4.65
4.4
5.0
5.70
5.84
kpa
0.22
27
109
14
32
4.81
4.61
3.0
2.3
166.93
209.97
%
0.99
14
32
11
20
5.94
4.40
2.6
1.8
—
—
—
0
0
8
9
9.41
4.35
2.1
2.9
—
—
—
0
0
10
17
6.31
4.23
4.1
2.0
—
—
—
0
0
26
113
2.66
4.22
4.6
5.0
1.31
2.35
mmol/l
0.36
21
84
29
134
2.53
4.16
3.0
1.8
—
—
—
0
0
9
14
6.85
4.06
1.2
1.6
—
—
—
0
0
10
19
5.63
3.92
1.1
1.1
—
—
—
0
0
14
44
3.47
3.91
3.4
1.4
11.40
10.38
g/l
0.31
14
37
29
138
2.45
3.90
3.0
1.9
—
—
—
0
0
70
477
2.11
3.90
16.4
2.7
—
—
—
0
0
14
40
3.82
3.76
3.4
1.6
0.06
0.20
g/l
0.30
14
33
9
16
5.98
3.73
4.3
2.1
—
—
—
0
0
11
27
4.37
3.49
1.3
1.7
—
—
—
0
0
22
97
2.55
3.45
1.4
2.6
0.20
0.21
g/l
0.13
22
86
7
10
7.35
3.41
1.9
1.1
—
—
—
0
0
7
10
7.35
3.41
3.3
2.3
—
—
—
0
0
7
10
7.35
3.41
3.3
2.3
—
—
—
0
0
7
10
7.35
3.41
3.3
2.3
—
—
—
0
0
7
10
7.35
3.41
3.3
2.3
—
—
—
0
0
74
531
2.01
3.40
16.8
6.8
1.19
1.21
mmol/l
0.84
67
442
60
401
1.98
3.37
6.0
3.2
—
—
—
0
0
16
61
2.87
3.29
3.3
1.7
—
—
—
0
0
67
471
1.95
3.20
14.7
6.1
1.19
1.20
mmol/l
0.72
67
422
11
31
3.80
3.08
1.4
1.4
0.09
0.04
iu/ml
—
6
6
11
31
3.80
3.08
7.3
1.3
0.24
0.22
g/l
0.35
11
31
9
21
4.54
3.06
1.9
1.3
—
—
—
0
0
5
5
10.35
3.00
2.0
1.4
1002.40
1014.40
u/ml
—
5
5
12
38
3.39
2.95
3.8
1.4
35.72
36.54
g/l
0.15
12
32
9
22
4.33
2.94
1.7
1.5
—
—
—
0
0
20
92
2.41
2.86
3.5
4.8
4.11
4.20
kpa
0.12
20
87
8
18
4.68
2.85
1.5
1.7
—
—
—
0
0
8
18
4.68
2.85
1.5
1.7
—
—
—
0
0
9
23
4.14
2.84
1.3
1.7
—
—
—
0
0
11
34
3.45
2.81
7.3
1.3
1.29
1.17
g/l
0.74
11
34
17
73
2.55
2.80
7.4
3.2
1.69
1.93
mmol/l
0.06
12
61
5
6
8.62
2.77
1.6
2.3
—
—
—
0
0
9
24
3.96
2.73
1.1
1.8
—
—
—
0
0
6
10
6.24
2.73
1.0
1.1
—
—
—
0
0
8
19
4.43
2.73
1.4
1.7
—
—
—
0
0
9
25
3.80
2.63
1.9
1.5
—
—
—
0
0
6
11
5.67
2.57
3.7
2.2
—
—
—
0
0
6
11
5.67
2.57
3.7
2.2
—
—
—
0
0
5
7
7.39
2.57
1.4
1.3
—
—
—
0
0
11
38
3.08
2.49
6.7
2.1
—
—
—
0
0
9
27
3.52
2.45
1.8
1.5
—
—
—
0
0
9
27
3.52
2.45
1.8
1.5
—
—
—
0
0
29
166
1.98
2.43
4.8
3.0
1.56
1.95
e6/l
0.15
19
102
6
12
5.20
2.43
1.0
1.7
—
—
—
0
0
8
22
3.82
2.41
1.6
1.2
—
—
—
0
0
7
18
4.06
2.29
13.3
2.3
49.14
62.56
%
—
7
18
49
339
1.75
2.26
3.7
3.0
50.47
33.74
u/l
0.41
49
322
84
973
0.55
2.20
5.4
5.2
2.41
2.58
mmol/l
0.81
76
866
71
548
1.72
2.18
16.1
15.7
1.47
1.29
inr
0.83
24
168
80
938
0.57
2.17
4.8
4.6
1.21
1.44
mmol/l
3.32
72
833
81
946
0.57
2.15
5.1
4.6
4.12
4.44
mmol/l
1.52
74
850
11
43
2.71
2.14
3.5
3.2
—
—
—
0
0
30
182
1.86
2.11
4.3
2.8
3.75
0.88
e6/l
0.55
20
115
7
22
3.31
1.91
1.4
1.6
—
—
—
0
0
7
22
3.31
1.91
1.1
1.2
—
—
—
0
0
9
34
2.78
1.91
1.6
1.4
—
—
—
0
0
30
188
1.79
1.90
1.2
1.3
0.97
1.33
u/ml
—
10
56
9
35
2.69
1.84
3.7
1.8
—
—
—
0
0
78
909
0.60
1.84
4.8
4.2
1.46
1.27
mmol/l
1.20
71
804
26
158
1.82
1.81
8.3
7.1
104.38
104.02
mmol/l
0.16
26
158
6
18
3.45
1.77
1.0
1.0
—
—
—
0
0
11
49
2.37
1.69
2.0
5.8
0.67
0.71
%
0.16
11
49
57
436
1.58
1.68
2.9
2.1
81.62
92.10
pmol/l
1.16
39
222
13
64
2.16
1.61
6.9
3.5
0.03
0.12
e6/l
1.11
13
64
6
22
2.81
1.45
1.0
1.5
—
—
—
0
0
43
317
1.55
1.44
4.9
3.0
0.67
0.46
e6/l
0.38
37
251
11
53
2.18
1.43
2.0
5.5
2.07
1.12
%
0.62
11
53
98
1061
0.60
1.29
74.9
25.1
34.50
39.64
%
7.48
91
990
5
19
2.70
1.23
2.6
4.0
—
—
—
0
0
95
1032
0.63
1.18
53.7
19.7
91.42
81.46
umol/l
1.63
95
1032
32
235
1.49
1.07
1.5
1.9
488.63
443.90
pmol/l
0.32
27
198
18
116
1.65
1.04
6.1
3.7
—
—
—
0
0
59
491
1.39
1.00
7.5
5.3
0.00
0.00
estimate
-0.00
14
99
60
501
1.39
1.00
6.1
4.1
0.00
0.00
estimate
-0.00
14
93
53
434
1.39
0.99
4.7
4.4
38.23
46.95
ng/l
0.25
40
335
59
493
1.38
0.97
6.2
4.1
0.00
0.00
estimate
-0.00
16
108
6
27
2.28
0.95
10.0
1.6
—
—
—
0
0
81
721
1.37
0.86
5.4
3.8
15.04
14.93
pmol/l
0.13
76
633
5
23
2.22
0.77
1.2
1.9
—
—
—
0
0
21
153
1.45
0.73
5.9
6.3
10.77
11.26
kpa
0.20
21
145
21
153
1.45
0.73
5.9
6.3
4.93
5.04
kpa
0.23
21
144
84
909
0.75
0.69
6.3
6.3
40.13
40.94
mmol/mol
0.29
77
831
89
951
0.76
0.61
5.9
5.0
6.36
6.10
mmol/l
0.59
83
845
86
923
0.76
0.61
38.4
16.2
69.06
75.81
ml/min/173m2
1.47
74
756
56
489
1.27
0.61
3.7
2.9
—
—
—
0
0
7
46
1.55
0.49
13.9
3.8
4.59
4.40
pmol/l
—
7
41
18
142
1.31
0.41
1.5
1.3
6.30
13.38
u/ml
—
6
47
13
97
1.38
0.41
2.5
1.7
1.72
1.67
%
0.08
13
81
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
7.00
—
0
5
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
14.92
—
0
15
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
4.34
—
0
11
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
34
293
1.22
0.39
7.9
4.4
0.00
0.00
estimate
-0.00
11
92
19
155
1.27
0.35
6.2
6.3
2.04
1.30
mmol/l
0.30
14
127
44
394
1.18
0.34
7.2
4.3
—
—
—
0
0
17
141
1.24
0.28
1.5
1.5
—
—
—
0
0
11
86
1.31
0.27
3.7
7.3
24.66
24.77
mmol/l
0.02
11
81
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
6
48
1.26
0.20
1.5
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
6
78
0.76
0.16
3.2
2.1
9.25
14.47
nmol/l
—
6
71
12
105
1.16
0.11
1.9
1.3
—
—
—
0
0
36
340
1.08
0.11
5.3
3.7
31.95
9.21
mg/mmol
0.96
28
212
81
829
0.93
0.10
61.0
20.7
15.53
15.12
%
0.57
81
811
35
336
1.06
0.06
4.2
5.1
25.86
20.90
%
0.75
17
162
88
893
0.95
0.05
6.5
4.6
2.06
1.99
mu/l
0.20
83
785
45
437
1.05
0.05
4.3
5.5
1.80
2.90
ug/l
0.76
40
383
12
129
0.92
0.04
13.2
9.0
—
—
—
0
0
97
977
0.96
0.01
51.7
16.9
30.35
26.14
mg/l
0.67
89
796
0
6
0.00
-0.00
0.0
1.8
—
11.20
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
1.0
—
100.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
3.5
13.00
216.07
u/ml
—
5
44
0
7
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
72.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
96.60
—
0
5
0
7
0.00
-0.00
0.0
3.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MONOCYTIC_LEUKAEMIA – Monocytic leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).